Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users

Authors:
  • SSSamuel Shapiro
    Samuel Shapiro
  • DSDennis Slone
    Dennis Slone
  • LRLynn Rosenberg
    Lynn Rosenberg
  • OMOlli S. Miettinen
    Olli S. Miettinen
  • PSPaul D. Stolley
    Paul D. Stolley
  • RKRobert C. Knapp
    Robert C. Knapp
  • TLThomas Leavitt
    Thomas Leavitt
  • WWWatson G. Watring
    Watson G. Watring
  • NRNeil B. Rosenshein
    Neil B. Rosenshein
  • JLJohn L. Lewis
    John L. Lewis
  • DSDavid Schottenfeld
    David Schottenfeld

Abstract
THE results of a recent study by Weiss and Sayvetz1 suggested that women who have used oral contraceptives of the combination type for at least one year have about half the risk of endometrial cancer experienced by other women. Their study also confirmed earlier observations2 3 4 that women who have used Oracon, a sequential oral contraceptive, are at higher risk than other women.This report describes a case–control study that was carried out to investigate the effects of oral-contraceptive use on the risk of endometrial cancer. The results support the findings of Weiss and Sayvetz in that we estimated the relative . . .